Irbesartan

Product NDC
72205-328
11-digit product format
722050328
Labeler code
72205
Product ID
72205-328_1f98fd95-e564-45b3-947f-45eba77f2af5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Irbesartan
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Novadoz Pharmaceuticals LLC
Application
ANDA219539
Marketing category
ANDA
Marketing start
2025-11-04
Substance
IRBESARTAN
Active strength
150 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219539-001IRBESARTANIRBESARTAN75MGTABLET / ORALAB2025-11-04
A219539-002IRBESARTANIRBESARTAN150MGTABLET / ORALAB2025-11-04
A219539-003IRBESARTANIRBESARTAN300MGTABLET / ORALAB2025-11-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A219539-001AB
A219539-002AB
A219539-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A219539-001IRBESARTAN75MGTABLET / ORALAB2025-11-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219539-002IRBESARTAN150MGTABLET / ORALAB2025-11-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219539-003IRBESARTAN300MGTABLET / ORALAB2025-11-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219539-001IRBESARTAN75MGTABLET / ORALAB2025-11-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219539-002IRBESARTAN150MGTABLET / ORALAB2025-11-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219539-003IRBESARTAN300MGTABLET / ORALAB2025-11-0431067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219539-001IRBESARTAN75MGTABLET / ORALAB2025-11-04a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219539-002IRBESARTAN150MGTABLET / ORALAB2025-11-04a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219539-003IRBESARTAN300MGTABLET / ORALAB2025-11-04a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A219539-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219539-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219539-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219539-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219539-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219539-003AB131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219539-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219539-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219539-003AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Irbesartan
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IRBESARTAN150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
J0E2756Z7NInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
200094Internal RxNorm lookup
200095Internal RxNorm lookup
200096Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1f98fd95-e564-45b3-947f-45eba77f2af5Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
34942a29-de4f-d63c-7755-ba18fe1411a0Product name620180619
a7349398-661d-d9fc-46df-7e128bbd61d9Product name520171113
e0eeb018-194e-4b70-a57d-bac47a97b8eaProduct name120160825

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72205-328-05Irbesartan500 in 1 BOTTLETABLET, FILM COATED5001
72205-328-06Irbesartan10 in 1 BLISTER PACKTABLET, FILM COATED101
72205-328-06Irbesartan10 in 1 CARTONTABLET, FILM COATED101
72205-328-10Irbesartan10 in 1 BOTTLETABLET, FILM COATED101
72205-328-30Irbesartan30 in 1 BOTTLETABLET, FILM COATED301
72205-328-90Irbesartan90 in 1 BOTTLETABLET, FILM COATED901
72205-328-99Irbesartan1000 in 1 BOTTLETABLET, FILM COATED10001

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IrbesartanIRBESARTANNovadoz Pharmaceuticals LLC1f98fd95-e564-45b3-947f-45eba77f2af52025-11-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219539
application number: ANDA219539
ndc (product): 72205-328

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200095irbesartan 150 MG Oral TabletPSN1f98fd95-e564-45b3-947f-45eba77f2af51
200096irbesartan 300 MG Oral TabletPSN1f98fd95-e564-45b3-947f-45eba77f2af51
200094irbesartan 75 MG Oral TabletPSN1f98fd95-e564-45b3-947f-45eba77f2af51
200095irbesartan 150 MG Oral TabletSCD1f98fd95-e564-45b3-947f-45eba77f2af51
200096irbesartan 300 MG Oral TabletSCD1f98fd95-e564-45b3-947f-45eba77f2af51
200094irbesartan 75 MG Oral TabletSCD1f98fd95-e564-45b3-947f-45eba77f2af51

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
72205-328-0572205032805500 TABLET, FILM COATED in 1 BOTTLE (72205-328-05) 2025-11-07NoNoCurrent
72205-328-067220503280610 BLISTER PACK in 1 CARTON (72205-328-06) / 10 TABLET, FILM COATED in 1 BLISTER PACK10 blister pack2025-11-07NoNoCurrent
72205-328-107220503281010 TABLET, FILM COATED in 1 BOTTLE (72205-328-10) 2025-11-07NoNoCurrent
72205-328-307220503283030 TABLET, FILM COATED in 1 BOTTLE (72205-328-30) 2025-11-07NoNoCurrent
72205-328-907220503289090 TABLET, FILM COATED in 1 BOTTLE (72205-328-90) 2025-11-07NoNoCurrent
72205-328-99722050328991000 TABLET, FILM COATED in 1 BOTTLE (72205-328-99) 2025-11-07NoNoCurrent